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Abstract
Several studies indicated the involvement of serotonin-3 (5-HT3) receptors in regulating alcohol-
drinking behavior. The objective of this study was to determine the involvement of 5-HT3 
receptors within the ventral tegmental area (VTA) in regulating ethanol self-administration by 
alcohol-preferring (P) rats. Standard two-lever operant chambers were used to examine the effects 
of 7 consecutive bilateral micro-infusions of ICS205-930 (ICS), a 5-HT3 receptor antagonist, 
directly into the posterior VTA on the acquisition and maintenance of 15% (v/v) ethanol self-
administration. P rats readily acquired ethanol self-administration by the 4th session. The three 
highest doses (0.125, 0.25 and 1.25 ug) of ICS prevented acquisition of ethanol self-
administration. During the acquisition post-injection period, all rats treated with ICS demonstrated 
higher responding on the ethanol lever, with the highest dose producing the greatest effect. In 
contrast, during the maintenance phase, the 3 highest doses (0.75, 1.0 and 1.25 ug) of ICS 
significantly increased responding on the ethanol lever; following the 7-day dosing regimen, 
responding on the ethanol lever returned to control levels. Micro-infusion of ICS into the posterior 
VTA did not alter the low responding on the water lever, and did not alter saccharin (0.0125% 
w/v) self-administration.. Micro-infusion of ICS into the anterior VTA did not alter ethanol self-
administration. Overall, the results of this study suggest that 5-HT3 receptors in the posterior VTA 
of the P rat may be involved in regulating ethanol self-administration. In addition, chronic operant 
ethanol self-administration, and/or repeated treatments with a 5-HT3 receptor antagonist may alter 
neuronal circuitry within the posterior VTA.
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Introduction
A role for serotonin-type 3 (5-HT3) receptors in mediating the actions of ethanol is 
suggested by several studies. Ethanol enhanced 5-HT3 receptor-mediated ion currents 
(Lovinger and White 1991; Sung et al., 2000), and 5-HT3 receptor antagonists inhibited the 
increase in extracellular dopamine (DA) levels in the nucleus accumbens elicited by ethanol 
when the antagonist was given systemically (Carboni et al., 1989; Wozniak et al., 1990) or 
locally (Campbell et al. 1996). In addition, systemic administration of 5-HT3 receptor 
antagonists suppressed voluntary ethanol consumption of rats under 24-hr free-choice 
conditions (Fadda et al., 1991; Knapp and Pohorecky 1992; McKinzie et al., 1998; Rodd-
Henricks et al., 2000). Furthermore, an in vivo microdialysis study (Campbell et al., 1996) 
demonstrated that local administration of a 5-HT3 receptor antagonist inhibited 5-HT3 
agonist- and ethanol - stimulated somatodendritic DA release in the ventral tegmental area 
(VTA), supporting a role for 5-HT3 receptors in regulating basal and ethanol -stimulated 
activity of VTA DA neurons.
In contrast to the effects of 5-HT3 receptor antagonists to reduce 24-hr ethanol intakes 
(Fadda et al., 1991; Knapp and Pohorecky 1992; McKinzie et al., 1998; Rodd-Henricks et 
al., 2000), under scheduled access conditions, several studies indicated that systemic 
injections of 5-HT3 receptor antagonists (at doses that were effective under 24-hr free-
choice alcohol drinking) had little effect on ethanol drinking or operant self-administration 
(Knapp and Pohorecky 1992; McKinzie et al., 1998, 2000; Svennsson et al., 1993; 
Beardsley et al., 1994), suggesting that conditioning factors may play a role in reducing the 
effectiveness of the antagonists. However, there are two studies (Hodge et al., 1993b; 
Tomkins et al., 1995) that reported a reduction in ethanol intake, under scheduled access 
conditions, following systemic administration of 5-HT3 antagonists. The apparent 
disagreement between these latter two studies and those cited above may be related to only 
very high doses being effective in one study (Hodge et al., 1993b), or the use of ondansetron 
in the other study (Tomkins et al., 1995), which did not produce a typical dose-response and 
had only small effects on ethanol intake.
Studies with the intracranial self-administration technique demonstrated that ethanol was 
self-infused into the posterior VTA but not the anterior VTA of alcohol-preferring (P) and 
Wistar rats (Rodd-Henricks et al., 2000; Rodd et al., 2004), suggesting that the posterior 
VTA is a neuroanatomical site supporting the reinforcing effects of ethanol . Additional 
studies indicated that co-administration of 5-HT3 receptor antagonists blocked the self-
infusions of ethanol into the posterior VTA of P and Wistar rats (Rodd-Henricks et al., 2003; 
Rodd et al., 2005b), suggesting that the reinforcing effects of ethanol within the posterior 
VTA are mediated through activation of local 5-HT3 receptors.
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There is evidence that the mesolimbic DA system is involved in regulating alcohol drinking 
(reviewed in Koob et al., 1998). Several microinjection studies indicated that the VTA is 
involved in regulating alcohol drinking (Hodge et al., 1993a, 1996; Katner et al., 1997; 
Nowak et al., 1998, 2000). Moreover, the studies of Hodge et al., (1993a) and Nowak et al., 
(2000) indicated that microinfusion of quinpirole, a DA D2 receptor agonist, reduced ethanol 
intake, suggesting that activation of VTA DA neurons is involved in maintaining ethanol 
drinking. Therefore, the objective of the present study was to examine the effects of micro-
injecting a 5-HT3 receptor antagonist into the VTA of P rats to test the hypothesis that 5-
HT3 receptors in the posterior VTA are involved in regulating ethanol self-administration.
Materials and methods
Animals
Naïve, female P rats from the 55th -57th generations weighed 250–320 g at the start of the 
study. Female rats were used mainly because adult female body weights and head size 
remain more constant than male rats, which yields better consistency and accuracy in 
stereotaxic placements (Ikemoto et al., 1997a, 1998; Rodd-Henricks et al., 2000). Female 
rats have been used in previous studies involving microinjection techniques that examined 
the VTA (Gatto et al., 1994; Rodd-Henricks et al., 2000, 2003; Rodd et al., 2005a, b). There 
has been no evidence that estrous cycle has an effect on operant behaviors (e.g., Rodd-
Henricks et al., 2000, 2002), as indicated by no major cyclical individual fluctuations in 
operant behavior in rats given access to ethanol over several weeks after responding was 
established; the usual average has been less than 10% variation across days.
Rats were double-housed upon arrival in the vivarium and were maintained on a 12-hr 
reverse light-dark cycle (lights off at 0900 hr) for at least two weeks before beginning 
experimental procedures. Food and fresh tap water were always available in the home cages. 
The vivaria and facilities are fully accredited by the Association for the Assessment and 
Accreditation of Laboratory Animal Care (AAALAC). All research protocols were approved 
by the Indiana University School of Medicine Institutional Animal Care and Use 
Committee. The final number of animals indicated for each experiment represents 90–95% 
of the total number that underwent surgery; 5–10% of the rats were excluded, mainly due to 
the loss of the guide cannula before completion of all experimental sessions. Any data 
accrued for these animals were not used because their injection sites could not be verified.
Surgical procedure
Prior to surgery, all rats were weighed and handled for at least 20 min daily over one week. 
All rats were stereotaxically implanted with bilateral 22-gauge guide cannula (Plastic One) 
under iosflurane anesthesia. The stereotaxic coordinates (Paxinos and Watson, 1998) 
targeted placement of the cannula tip 1.0 mm above the VTA region of interest. Placements 
for the posterior VTA were aimed at -5.4 to –5.8 mm bregma, 8.5 mm ventral from the 
surface of the skull, and each cannula was 2.1 mm lateral in the right or left hemisphere at a 
10-degree angle from vertical such that the cannula tip terminated above and slightly lateral 
to the midline posterior VTA. Coordinates for bilateral placements aimed above the anterior 
VTA were –4.6 to −4.8 mm bregma, 8.5 mm ventral from the surface of the skull and 2.1 
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mm lateral from the midline at a 10-degree angle from vertical. Except for when 
microinjections were being conducted, a 28-gauge capped stylet was threaded in place to 
seal each guide cannula. The stylet extended 0.5 mm beyond the tip of the guide. Rats were 
individually housed after surgery and allowed 7 days to recover before experimental 
procedures began. Animals were handled daily following surgery day. Body weights and 
general behavior were monitored to ensure full recovery prior to commencing experimental 
sessions.
Ethanol Self-Administration
The rats were experimentally naive and were not acclimated to the operant chamber before 
commencement of operant sessions and data collection. Ethanol self-administration 
experiments were conducted in standard two-lever operant chambers (Coulbourn 
Instruments, Allentown, PA) contained within ventilated, sound-attenuated enclosures. In 
each chamber, the two operant levers were located on the same wall, 15 cm above the grid 
floor and 13 cm apart. Directly beneath each lever was a trough through which a dipper cup 
(0.1 ml) rose to deliver response-contingent fluid. Upon a reinforced response, a small cue 
light was illuminated within the drinking trough during the 4 sec access to the dipper cup. 
One lever activated a dipper that delivered water and the other activated a lever that 
delivered the ethanol solution. The assignment of the water and ethanol levers in the left or 
right position was counterbalanced among subjects, but the levers remained in the same 
position throughout for each rat. Operant chambers were illuminated by dim lights during 
test sessions. All sessions were 60 min in duration and were conducted daily during the dark 
period.
For testing, subjects were brought to a microinjection area, the stylet was removed, and an 
injection cannula was screwed into place. When secured, the microinjection cannula 
extended 1.0 mm beyond the tip of the guide. During the microinjection procedure, rats were 
housed in a glass cylinder (diameter – 24 cm). The right hemisphere VTA was always 
infused first. The rate of infusions was regulated by a Harvard microinjection pump at a 
steady rate of 0.5 μl of infusate/30 sec/side. The microinjector cannula remained inserted for 
an additional 30 sec to allow the infusate to diffuse away from the cannula tip. Following the 
initial injection into the right VTA, the left side was injected with the same infusate. Again, 
a 30 sec post-injection period was allowed. Immediately following the left hemisphere 
microinjection, rats were transported into the adjacent operant testing room and placed into 
their assigned chambers. The 5-HT3 antagonist, ICS 205,930 (ICS; Sigma), was dissolved in 
artificial cerebrospinal fluid (aCSF); the solution was adjusted to pH 7.4 ± 0.1 with 0.1 M 
HCl or 0.1 M NaOH. The aCSF consisted of (in mM): 120.0 NaCl, 4.8 KCl, 1.2 KH2PO4, 
1.2 Mg SO4, 25.0 NaHCO3, 2.5 CaCl2, and 10.0 d-glucose.
Micro-infusion of ICS during Acquisition of Ethanol Self-Administration
For the acquisition experiment, female P rats (n = 46) were randomly assigned to one of six 
groups (n = 6–9/group). To evaluate whether the microinjection procedure might alter the 
acquisition of oral operant ethanol self-administration, a no-injection control was included in 
the experimental design. The no-injection control group was handled exactly as all other 
microinjected groups, except that the injector was not screwed into the dummy cannulae 
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(animals were placed into glass cylinders and the injection pump was activated). A vehicle 
group received infusions of aCSF into both hemispheres for seven consecutive sessions. The 
other groups were given 0.075, 0.125, 0.25, or 1.25 μg ICS/side for all seven sessions. The 
ICS compound was chosen because this antagonist is readily soluble in aCSF and has been 
used in previous micro-infusions (Rodd-Henricks et al., 2003; Rodd et al., 2005a,b) and 
microdialysis (Campbell et al., 1996) experiments.
Following the surgery recovery period, rats were given two days of mock injections, i.e., 
they were taken into the microinjection room and were treated as if they were to be injected 
(stylets removed, injectors attached, 30 sec post-injection period), except that no injection 
was given. On the day after the second mock injection, rats were microinjected with their 
assigned infusate and were immediately transferred to the operant testing room. Rats had 
never entered the operant testing room prior to this first operant test session. Both the EtOH 
(15% v/v) and water levers were maintained on a continuous (fixed-ratio; FR 1) 
reinforcement schedule. Rats received bilateral microinjections into the posterior VTA daily 
prior to each of the 7 acquisition sessions. Following this 7-day microinjection phase, all rats 
were given 6 more daily operant sessions without microinjections.
Micro-infusion of ICS during Maintenance of Ethanol Self-Administration
Naïve female P rats (n = 37) were placed into the operant chamber with access to the ethanol 
solution and water on a FR1 schedule of reinforcement. Rats were allowed to acquire 
ethanol self-administration on the FR1 schedule for 4 weeks. The reinforcement schedule on 
the ethanol lever was then increased to FR3 in weeks 5 – 7 and to FR5 in weeks 8–10. The 
response requirement was increased to demonstrate that the ethanol solution was more 
reinforcing than water, and to have a baseline level that would permit measurement of drug 
effects that yielded either increases or decreases in responding. Water was maintained on an 
FR1 schedule throughout. During 10 weeks of ethanol self-administration, between-session, 
within-subject variation in responding averaged less than 10% of total responding for all 
rats.
For all maintenance experiments, cannula implants were performed after long-term 
maintained responding was well established. Surgeries were performed on the 71st or 72nd 
day of operant exposure to ethanol, and were performed on all groups equally for both days. 
After recovery, operant sessions were re-initiated. Rats were randomly assigned to one of six 
groups (n = 6–7/group). A vehicle group received infusions of aCSF in both hemispheres for 
seven consecutive sessions. The other groups were given 0.25, 0.5, 0.75, 1.0 or 1.25 μg ICS/
side for all seven sessions. Higher doses of ICS were tested in the maintenance than 
acquisition experiment because initial results indicated that the 0.25 μg dose had little effect 
on responding during the maintenance phase. On the 5th and 6th day following surgery, all 
rats were processed through the mock injection procedure outlined in the acquisition 
experiment, and in subsequent sessions the rats were given bilateral microinjections 
immediately before the 7 operant sessions. Following the microinjection phase of the 
experiment, all rats were tested in operant sessions for 7 additional daily sessions without 
further microinjections.
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Micro-infusion of ICS during Maintenance of Saccharin (SAC) Self-Administration
P rats acquire saccharin self-administration at a slower, less uniform rate than EtOH 
(Toalston et al., 2008). The mean number of daily 1 hr sessions required for a P rat to 
acquire saccharin (0.0125% w/v) self-administration is about 10–13 (Toalston et al., 2008; 
current data set), while 95% of P rats will acquire operant oral self-administration of 15% 
EtOH in 4 sessions (Rodd-Henricks et al., 2002; Toalston et al., 2008, current data). In 
contrast, it takes approximately 19 daily sessions for 85% of P rats to acquire consistent 
saccharin self-administration (Toalston et al., 2008; current data). Therefore, it is impractical 
to examine the effects of compounds on the acquisition of saccharin self-administration in P 
rats.
Similar to the experiment examining the effects of ICS on the maintenance of ethanol 
operant self-administration, naïve female P rats (n = 15) were placed into the operant 
chamber with access to a SAC (0.0125 % w/v) solution in one dipper and water in the other 
dipper, with both dippers on a FR1 schedule of reinforcement. The reinforcement schedule 
on the SAC lever was increased to FR3 in weeks 5 – 7 and to FR5 in weeks 8–10. Water 
was maintained on an FR1 schedule of reinforcement. All other handling, surgery, and 
experimental protocols were as described in the ethanol maintenance experiment. However, 
rats were only assigned to two groups, an aCSF vehicle (n = 7) or 1.25 μg ICS/side (n = 8) 
group. The 1.25- μg dose was selected based upon the effects of this dose on ethanol self-
administration. Rats received bilateral microinjections of the assigned infusate immediately 
prior to 7 consecutive daily sessions, and then were allowed to respond for saccharin for 7 
additional daily sessions.
Micro-infusion of ICS into the Anterior VTA during Maintenance of Ethanol Self-
Administration
Rats were treated identically to animals tested in the posterior VTA maintenance study. Rats 
were randomly assigned to one of three groups (n = 5–7/group; n = 17 total). A vehicle 
group received infusions of aCSF in both hemispheres for seven consecutive sessions. The 
other groups were given 0.75 or 1.25 μg ICS/side for all seven sessions. On the 5th and 6th 
day following surgery, all rats were processed through the mock injection procedure. 
Following the microinjection phase of the experiment, all rats were allowed to self-
administer ethanol for 7 more daily sessions without further microinjections.
Histology
All rats that completed the experiments received a 1% bromophenol blue solution infusion 
into the cannula sites after CO2 euthanasia. Brains were removed and immediately frozen at 
–70° C. To perform histology, frozen brains were equilibrated at –15° C in a cryostat 
microtome, and then sliced into 40 um sections. The sections were stained with cresyl violet 
and examined under a light microscope for verification of the injection site using the rat 
brain atlas of Paxinos and Watson (1998).
Statistical Analyses
Analyses for the acquisition data consisted of a mixed factor ANOVA with a between-
subject variable of ‘group' and a repeated measure of ‘session.' Lever discrimination was 
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examined by contrasting ethanol and water lever responses within each group. Data analyses 
for the maintenance experiment consisted of a mixed factor ANOVA with a between-subject 
variable of ‘group' and a repeated measure of ‘session.' In all experiments, data generated 
during the post-injection period were analyzed with a similar ‘group' by ‘session' mixed 
factor ANOVA.
Results
The posterior VTA was defined as the VTA region at the level of the interpeduncular 
nucleus, coronal sections at –5.3 to –6.0 mm from bregma. The anterior VTA was defined as 
the VTA between –4.8 to –5.2 mm from bregma (Fig. 1). Cannula placements outside the 
VTA included injection sites located in the substantia nigra, interpeduncular nucleus, red 
nucleus, and caudal linear nucleus of the raphe. These rats were excluded from the study (n 
= 3).
Micro-infusion of ICS into the Posterior VTA during Acquisition of Ethanol Self-
Administration
In agreement with previous studies (Rodd-Henricks et al., 2002), P rats readily learned to 
distinguish the ethanol lever from the water lever within 4 sessions, without any prior 
training or shaping experience (Fig. 2). Lever discrimination, preference for responding on 
one lever compared to another lever, was evident in the no-injection control group during 
the 3rd microinjection session (F1,5 = 11.85; p = 0.02) and in the aCSF group during the 4th 
session. By the 4th session, responding on the ethanol lever increased to 30–35 responses/
session, whereas responses on the water lever decreased to less than 10 responses/session. 
During the 4th–7th microinjection sessions, the no-injection, aCSF, and 0.075 μg ICS/side 
groups all showed a preference for responding on the ethanol lever compared to the water 
lever (F values > 14.96; p values < 0.006).
The analysis revealed that there was a significant effect of administration of ICS into the 
posterior VTA on the acquisition of ethanol self-administration (Fig. 2; group - F5,40 = 6.8; 
p < 0.001; session - F6,35 = 2.48; p = 0.041) and that this effect varied across injection 
session (group x session – F30,195 = 1.7; p = 0.018). The significant interaction term justified 
decomposing the data by performing individual ANOVAs on each session with the 
dependent variable of group. During the 1st and 2nd session, bilateral microinjection of ICS 
had no effect on either ethanol or water lever responding (F values 5,40 < 2.0; p values > 
0.102). On the 3rd microinjection session, there was a significant effect of group (F5,40 = 
5.8; p < 0.0001), with post-hoc comparisons (Tukey's b) indicating that the no-injection 
control, aCSF, and 0.075 μg ICS/side responded significantly higher on the ethanol lever 
than did rats administered 0.125, 0.25, and 1.25 μg ICS/side. During the 4th-7th 
microinjection sessions, bilateral microinjection of 0.125, 0.25, or 1.25 μg ICS/side reduced 
responding on the ethanol lever (group F values 5,40 > 3.2; p values < 0.016). Post-hoc 
comparisons performed on these sessions indicated that ethanol lever responding in the 
0.125and 1.25 μg ICS/side groups was significantly lower than in the no-injection, aCSF, 
and 0.075 μg ICS groups during sessions 4–7, while the 0.25 μg ICS groups was reduced in 
sessions 4, 5, and 7.
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At no point during the microinjection phase of the experiment did ICS impact the amount of 
responding on the water lever (Fig. 3; group - F5,40 = 6.8; p < 0.001; group x session – 
F30,195 = 0.93; p = 0.577). There was a significant effect of ‘session’ on water responding 
(F6,35 = 4.6; p = 0.002). This effect was based upon a gradual reduction in water responding 
from the 1st session (total average 15.7 ± 1.7) to the 7th session (total average 9.4 ± 1.2).
Examining ethanol responding during the post-injection phase following 7 consecutive 
bilateral microinjections of ICS revealed that there was a significant carryover (sessions 8–
13) effect (Fig. 2; group – F5,40 = 4.2; p = 0.004, session - F5,36 = 36.0; p < 0.0001) and that 
this carryover effect varied across injection session (group x session – F25,200 = 2.5; p < 
0.001). The 0.125, 0.25, and 1.25 μg ICS groups readily acquired ethanol self-administration 
when ICS microinjections were terminated, as indicated by the increased responding on the 
ethanol lever without any change in responding on the water lever during the post-injection 
phase. Isolating the interaction term by performing separate ANOVAs on each session 
revealed that, during the 1st and 2nd post-injection session, there were no group differences 
(F values 5,40 < 0.4; p values > 0.94). There were significant group differences during the 3rd 
– 6th post-injection sessions (F values 5,40 > 3.6; p values < 0.009). Post-hoc comparisons 
indicated that, during the 3rd post-injection session, rats in the 1.25 μg ICS group responded 
more than all other groups, and rats in the 0.075 μg ICS group responded more on the 
ethanol lever than no-injection and aCSF groups. During the 4th post-injection session, rats 
administered the highest concentration of ICS (1.25 μg ICS) responded more than all other 
groups. All groups that received microinjections of ICS during the microinjection period 
responded more than the no-injection and aCSF groups during the 4th – 6th post-injection 
session.
Although all ICS groups significantly increased responding on the ethanol lever during the 
post-injection period, responses on the water lever did not change during this period (Fig. 3; 
group - F5,40 = 1.8; p = 0.12, session - F5,36 = 1.4; p = 0.24; group x session – F25,200 = 
0.953; p = 0.533).
Micro-infusion of ICS into the Posterior VTA during Maintenance of Ethanol Self-
Administration
For the maintenance experiments, a concurrent FR5-FR1 schedule of reinforcement was 
used to increase the work requirement for ethanol while maintaining the low requirement for 
water. This schedule has been used previously to assess the reinforcing effects of EtOH 
(Rodd-Henricks et al., 2002). With this procedure, responses on the water lever remained 
low (average responses for all microinjection sessions was 12 responses/session, with a 
range of 10 – 14 responses/session), and were not altered by any of the treatments with ICS 
(data not shown; all p values > 0.67).
An ANOVA performed on the last 3 sessions prior to surgery revealed that all groups 
responded similarly on the EtOH lever (F5,36 = 0.4; p = 0.83). Additionally, a mixed factor 
ANOVA performed on recovery days 3–5 indicated that responding on the ethanol lever was 
not different among the groups (Fig. 4; group - F5,31 = 0.1; p = 0.991; session - F2,62 = 0.95; 
p = 0.393; group x session - F10,62 = 0.79; p = 0.643). The average water responses prior to 
surgery were 12 responses/session for all groups, with no significant differences between 
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groups (range of 11 – 14 responses/session). Following surgery, water lever responding was 
maintained at a low level for all groups, with no group differences (average of 11 responses/
session; range of 9 – 13 responses/session).
The analysis revealed that there was a significant effect of administration of ICS into the 
posterior VTA on the maintenance of ethanol self-administration (Fig. 4; group - F5,31 = 4.3; 
p = 0.004; session - F6,186 = 3.3; p = 0.004), and that this effect varied across injection 
sessions (group x session - F30,186 = 2.7; p < 0.001). Individual ANOVAs performed on 
each microinjection session revealed a significant effect of group for all sessions (F 
values 5,31 > 2.9; p values < 0.028). Post-hoc comparisons (Tukey's b) revealed that on the 
1st microinjection session, the group given 1.25 μg ICS/side responded more on the ethanol 
lever than did rats given aCSF. During the 2nd microinjection session, rats administered 
0.75 and 1.25 μg ICS/side responded significantly more on the ethanol lever than rats given 
aCSF, or 0.25 or 0.50 μg ICS/side. During the 3rd and 4th microinjection sessions, rats 
given the three highest doses of ICS (0.75, 1.0 and 1.25 μg ICS/side) responded more on the 
ethanol lever than all other groups. During the 5th–7th microinjection sessions, rats 
administered 0.75 and 1.0 μg ICS/side responded more on the EtOH lever than all other 
groups.
A mixed-factor ANOVA conducted on the initial 7 post-injections sessions revealed a 
carryover effect of ICS microinjections (Fig. 4; session F6,186 = 10.8; p < 0.001; group x 
session - F30,186 = 4.1; p < 0.001). On the 1st post-injection session, rats administered 0.75 
and 1.0 μg ICS/side responded more on the ethanol lever than all other groups (F5,31 = 4.2; p 
= 0.005; Tukey's b p < 0.05). During the 2nd and 3rd post-injection sessions, rats previously 
administered the three highest levels of ICS (0.75, 1.0 and 1.25 μg ICS/side) responded 
more on the ethanol lever than all other groups (F values 5, 31 > 3.7; p values > 0.011). 
There was no significant effect of group on any other post-injection session (p values > 
0.176). Responses on the water lever were not elevated during the post-injection sessions, 
and did not differ between groups (p values > 0.56).
Micro-infusion of ICS into the Posterior VTA during Maintenance of SAC Self-
Administration
P rats readily learn to self-administer 0.0125% (w/v) SAC without any prior training or 
shaping procedures. In a 2-lever operant paradigm, P rats readily discriminated the SAC 
from the water lever. With a concurrent FR5-FR1 schedule of reinforcement for SAC versus 
water, P rats responded significantly more on the SAC than water lever. Responses on the 
water lever with saccharin concurrently available were low (data not shown), and similar to 
responses on the water lever when ethanol was concurrently available (Fig. 3).
An ANOVA performed on the average of the last 3 sessions prior to surgery revealed that 
both groups responded similarly on the SAC lever (Fig. 5; F1,13 = 0.07; p = 0.80). 
Additionally, a mixed factor ANOVA performed on recovery days 3–5 indicated that 
recovery from surgery was equivalent in both groups (Fig. 5; all p values > 0.449). The 
overall analysis revealed that administration of 1.25 μg ICS/side into the posterior VTA had 
no effect on the maintenance of SAC self-administration (Fig. 5; group - F1,13 = 0.05; p = 
0.83; session - F6,78 = 1.05; p = 0.4; group x session - F6,78 = 1.02; p = 0.42). Additionally, 
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there was no carryover effect of bilateral administration of ICS directly into the posterior 
VTA on SAC responding following the termination of ICS injections (all p values > 0.69).
Micro-infusion of ICS into the Anterior VTA during Maintenance of Ethanol Self-
Administration
Overall, the analysis revealed that microinjections of ICS into the anterior VTA had no 
effect on ethanol self-administration. An ANOVA performed on the last 3 sessions prior to 
surgery revealed that all groups responded similarly on the ethanol lever (F2,16 = 0.7; p = 
0.53). The analysis revealed that there was no significant effect of administration of ICS into 
the anterior VTA on the maintenance of operant ethanol self-administration (Fig. 6; group - 
F2,16 = 0.95; p = 0.41; session - F6,96 = 1.4; p = 0.211; group x session – F12,96 = 1.5; p = 
0.11).
The average responses on the water lever prior to surgery were 14 responses/session for all 
groups, with no significant differences between groups (range of 12 – 15 responses/session). 
Following surgery, responding on the water lever was maintained at a low level for all 
groups, with no group differences (average of 12 responses/session; range of 11 – 14 
responses/session).
Discussion
The major findings of this study were that local administration of the 5-HT3 receptor 
antagonist ICS into the posterior VTA had divergent effects on ethanol self-administration 
depending on ethanol drinking experience; decreasing ethanol self-administration during 
acquisition (Fig. 2) and enhancing ethanol self-administration during maintenance (Fig. 4). 
Furthermore, ICS microinjections during the acquisition period appeared to produce 
alterations within the posterior VTA that resulted in markedly increased ethanol self-
administration during the post-injection phase (Fig. 2). Overall, the results of this study 
support the hypothesis that 5-HT3 receptors within the posterior VTA are involved in 
regulating ethanol intake. In contrast to its effects of enhancing ethanol self-administration 
during maintenance, the ICS compound had no effect on responses on the water lever or on 
saccharin self-administration under these conditions (Figs. 3 and 5). In addition, the 
regulation of ethanol self-administration by 5-HT3 receptors within the VTA appears to be 
localized to the posterior rather than the anterior portion (Fig. 6). The posterior VTA 
receives significant 5-HT input (Herve et al., 1987) and 5-HT terminals synapse on 
mesolimbic DA neurons (Van Bockstaele et al., 1994). However, the localization of 5-HT3 
receptors within the anterior VTA has not been established.
With regard to acquisition, the three highest doses of ICS prevented acquisition of ethanol 
self-administration when microinfused prior to each of the first 7 sessions (Fig. 2). These 
results suggest that activation of 5-HT3 receptors within the posterior VTA may be needed 
for acquisition of oral ethanol self-administration. Apparently, these doses may be high 
enough to block the activating (Campbell et al., 1996; Lovenger and White, 1991; Sung et 
al., 2000) and reinforcing (Rodd-Henricks et al., 2003; Rodd et al., 2005b) effects of ethanol 
at 5-HT3 receptors in the VTA. Under acquisition conditions, the reinforcing effects of 
ethanol may be blocked by ICS, and, therefore, the P rats do not increase responding on the 
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ethanol lever and demonstrate lever discrimination. Alternatively, it is possible that ICS may 
be interfering with learning the operant task, resulting in lower responses on the ethanol 
lever. However, this latter possibility is not compatible with the higher responding that was 
observed for the ICS treated group during the post-injection sessions. If the ICS compound 
was interfering with learning then responses on the ethanol lever during the post-injection 
sessions should be similar for the control and ICS groups. In support of the idea that local 
microinjection of the ICS compound was not interfering with learning the operant task, a 
previous study (Rodd et al., 2005b) indicated that local co-administration of 200 μM ICS 
into the posterior VTA did not interfere with acquisition of acetaldehyde self-infusions.
During the post-injection acquisition sessions, the 0.125 and 0.25 μg ICS treated groups 
acquired ethanol self-administration behavior within 3 sessions, and all 4 groups previously 
microinjected with ICS responded significantly more on the ethanol lever than did the two 
control groups (Fig. 2), suggesting that the ICS pretreatment regimen may have produced 
changes within the posterior VTA. A pharmacological effect on 5-HT3 receptors as opposed 
to a behavioral contrast effect during the post-injection period is suggested by the findings 
that the 0.125 and 1.25 μg doses produced the same effects in reducing ethanol responding 
during the initial acquisition sessions, whereas the 1.25 μg-dose-group had significantly 
higher responding on the ethanol lever than all other groups during the post-injection phase 
(Fig. 2). A solely behavioral contrast or compensatory response during the post-injection 
phase would have been suggested if both the 0.125 and 1.25 μg doses produced similar 
effects during the post-injection phase. In addition, it is not clear if a similar post-injection 
increase in responding would have occurred if saccharin had been used instead of ethanol. 
The prediction would be that, since the reinforcing effects of saccharin are not mediated 
through activation of 5-HT3 receptors in the posterior VTA (Fig. 5), then no markedly 
enhanced responding for saccharin should be observed in the post-injection period.
In general, chronic administration of an antagonist would be expected to produce up-
regulation of the receptor. Because local administration of a 5-HT3 receptor agonist 
increases DA neuronal activity, as indicated by increased somatodendritic release of DA 
(Campbell et al., 1996), the expectation is that the pretreatment regimen with local ICS 
administration up regulates 5-HT3 receptors and increases the overall net excitability of 
VTA DA neurons. The up regulation of 5-HT3 receptors in the posterior VTA increases the 
excitatory effects of ethanol on VTA DA neurons and, thereby, increases the reinforcing 
effects of ethanol. On the other hand, evidence indicates that repeated systemic injections of 
5-HT3 receptor antagonists decreased the number of spontaneously active VTA DA cells in 
rodents (Minabe et al., 1991; Prisco et al., 1992; Rasmussen et al., 1991), and reduced DA 
neurotransmission in the nucleus accumbens (Liu et al., 2006). However, with systemic 
injections, the 5-HT3 receptor antagonists are producing effects at multiple CNS sites and 
pathways, which may have the end result of decreasing VTA DA neuronal activity, whereas 
local administration of the antagonist is having a direct effect within the VTA, which could 
produce up-regulation of 5-HT3 receptors in this region.
In contrast to the effects of ICS during acquisition of ethanol self-administration (Fig. 2), 
microinjection of ICS during maintenance had no effect at a dose that blocked acquisition; 
moreover, at higher doses, ICS significantly increased ethanol self-administration (Fig. 4). 
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Perhaps the best illustration of this divergent effect of ICS on oral ethanol self-
administration is the 1.25 μg ICS group (reduction during acquisition, increase during 
maintenance). These results suggest that different mechanisms within the posterior VTA 
may be involved in acquisition and maintenance of ethanol self-administration. The concept 
that different mechanisms may underlie acquisition and maintenance of alcohol intake is 
consistent with published findings (Ford et al., 2008; Ikemoto et al., 1997b). The 
development of mechanisms maintaining ethanol self-administration may reflect the impact 
of a combination of factors, e.g., chronic intermittent ethanol exposure, the reinforcing 
effects of ethanol, learning and maintaining high responding on the appropriate lever, and 
conditioning factors associated with the operant chamber. The increased responding on the 
ethanol lever by the 0.75, 1.0 and 1.25 μg ICS groups, compared to the control group (Fig. 
4), suggests that alterations in local 5-HT3 receptors and/or local circuits may have 
developed with chronic ethanol self-administration. One possibility is that daily ethanol self-
administration has produced up-regulation of 5-HT3 receptors in the posterior VTA, and the 
3 highest doses of ICS only partially block the 5-HT3 receptors. Under conditions of partial 
blockade of the receptor, the P rats increase their responding on the ethanol lever in an 
attempt to overcome this partial inhibition. An alternative explanation is that a history of 
ethanol self-administration has produced alterations in neural circuits within the posterior 
VTA, so that now 5-HT3 receptors regulate the upper limit for ethanol self-administration; 
blocking these receptors removes this upper limit, resulting in the P rats self-administering 
more ethanol. In addition, at the highest dose used in the maintenance phase, the ICS 
compound, with repeated microinjections, may be diffusing to adjacent sites and/or having 
an effect at the GABAA receptor (Klein et al., 1994), in addition to its effect on local 5-HT3 
receptors, to produce mixed effects on ethanol self-administration.
Based upon the general findings in the literature, the expected results of micro-injecting a 5-
HT3 receptor antagonist into the VTA would have been to reduce ethanol self-
administration. Although a reduction during the acquisition phase was observed (Fig. 2), an 
increase or no effect of ICS was found during the maintenance phase (Fig. 4). First, the 
differences observed with ICS between the acquisition and maintenance phases suggest that 
ethanol self-administration may have produced alterations in the posterior VTA neuronal 
circuits. Chronic alcohol drinking (Rodd et al., 2005c,d) or repeated local ethanol 
administration (Ding et al., 2009b) produced alterations in the posterior VTA, which 
increased the sensitivity of this region to the stimulating and reinforcing effects of ethanol. 
Therefore, changes within the posterior VTA neuronal circuitry may have resulted in ICS 
activating circuits and enhancing the reinforcing effects of ethanol.
The finding that local microinjection of ICS into the posterior VTA increased ethanol self-
administration is in apparent disagreement with several studies reporting that 5-HT3 receptor 
antagonists reduced ethanol intake of rats under 24-hr free-choice conditions (Fadda et al., 
1991; Knapp and Pohorecky 1992; McKinzie et al., 1998, 2000; Rodd-Henricks et al., 
2000). Two factors need to be considered to explain this apparent disagreement. First, 
systemic injections were used in the alcohol drinking studies, and the 5-HT3 receptor 
antagonists are acting in multiple regions; these combined effects could be contributing to 
reducing 24-hr free-choice drinking. Second, doses of 5-HT3 receptor antagonists that 
reduce 24-hr free-choice drinking are not effective in reducing ethanol intake under 
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scheduled access conditions (Beardsley et al., 1994; Knapp and Pohorecky, 1992; McKinzie 
et al., 1998, 2000; Svennsson et al., 1993), possibly due to conditioning factors having a role 
in altering the activity of the 5-HT system and reducing the effectiveness of the 5-HT3 
receptor antagonists. It is possible that conditioning factors may be altering the activity of 5-
HT and other pathways to the posterior VTA resulting in ICS producing a local effect, 
which enhances on-going ethanol self-administration.
The lack of effect of ICS injected into the anterior VTA on ethanol self-administration (Fig. 
6) may be a result of fewer 5-HT3 receptors being present in this region, and/or the anterior 
VTA is not involved in mediating alcohol drinking behavior. A microdialysis study (Liu et 
al., 2006b) suggested that there was a heterogeneous distribution of functional 5-HT3 
receptors within the VTA with higher numbers in the posterior than anterior VTA. There is 
also evidence for a heterogeneous distribution within the VTA for the reinforcing effects of 
ethanol (Rodd- Henricks et al., 2000) and the reinforcing effects of activation of 5-HT3 
receptors (Rodd et al., 2007), with the posterior VTA supporting reinforcement, and the 
anterior VTA not supporting reinforcement processes. Therefore, it is possible that the lack 
of effect of ICS in the anterior VTA on ethanol self-administration may be due to fewer 
functional 5-HT3 receptors in this region, and/or the lack of involvement of the anterior 
VTA in mediating ethanol reinforcement.
Studies using microinjection techniques to examine effects on behavior have two major 
problems to address, i.e., site specificity and pharmacological selectivity. There will always 
be diffusion of the injected compound away from the site of injection. A concern is whether 
the observed effect is due to the target site, a site adjacent to the target, or a combination of 
both. The finding that the highest dose of ICS infused into the anterior VTA did not have an 
effect on ethanol self-administration suggests that there is a limited effective diffusion range 
for the ICS compound, since injection sites in the anterior VTA were 0.4 to 0.6 mm from the 
posterior VTA. The most prominent structure adjacent to the posterior VTA is the substantia 
nigra (SN). Effects in this region would be expected to alter general motor performance. 
However, since ICS did not alter saccharin responding (Fig. 5), this would suggest that ICS 
is not diffusing to the SN in sufficient quantities to alter motor performance. The possibility 
that diffusion to other adjacent sites (e.g., the red nucleus) might be influencing the results 
cannot be ruled out.
The ICS compound has also been reported to act at GABAA receptors, producing a bi- 
phasic response, depending upon the concentration of the ICS and the subunit composition 
of the GABAA receptor, with the higher μM concentrations of ICS generally inhibiting 
GABA- mediated Cl− currents (Klein et al., 1994). There is microdialysis evidence that local 
administration of a GABAA receptor antagonist into the posterior VTA has little effect on 
extracellular levels of DA in the nucleus accumbens, suggesting that DA neurons in this 
region are not under tonic GABAA receptor mediated inhibition (Ding et al., 2009a), 
whereas DA neurons in the anterior VTA appear to be under tonic GABAA receptor 
mediated inhibition (Ikemoto et al., 1997c). If increases in DA neuronal activity are 
associated with the reinforcing effects of ethanol and ethanol drinking, then the inhibitory 
effects of ICS on acquisition of ethanol self-administration may not be a result of its actions 
at GABAA receptors. However, since ICS had an opposite effect on ethanol self-
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administration under maintenance conditions, suggesting that ethanol self-administration 
may have altered neuronal circuitry within the posterior VTA, it is possible that the effects 
of ICS in enhancing on-going ethanol self- administration may be due in part through an 
action at GABAA receptors.
The saccharin experiment was conducted to ensure that the microinjection of ICS into the 
posterior VTA did not have a general effect on disrupting operant behavior. Since the 
highest dose of ICS did not alter saccharin responding (Fig. 5), these results suggest that the 
enhanced maintenance responding for ethanol produced by ICS (Fig. 4) may be a result of a 
history of ethanol self-administration by the P rats. In addition, the observation that the 
highest dose of ICS did not alter saccharin responding suggests that the reduced responding 
on the ethanol lever produced by ICS during the acquisition experiment was not due to 
impaired motor control.
In conclusion, the results of the present study indicate that 5-HT3 receptors within the 
posterior VTA are involved in regulating ethanol intake and reinforcement. A history of 
ethanol self-administration or pretreatment with local administration of a 5-HT3 receptor 
antagonist may alter 5-HT3 receptor function and/or neural circuits within the posterior 
VTA.
Acknowledgments
Supported in part by NIAAA grants AA10717, AA10721 and AA07611.
References
Beardsley PM, Lopez OT, Gullikson G, Flynn D. Serotonin 5-HT3 antagonists fail to affect ethanol 
self-administration of rats. Alcohol. 1994; 11:389–395. [PubMed: 7818797] 
Campbell AD, Kohl RR, McBride WJ. Serotonin-3 receptor and ethanol-stimulated somatodendritic 
dopamine release. Alcohol. 1996; 13:569–574. [PubMed: 8949951] 
Carboni E, Acquas E, Frau R, DiChiara G. Differential inhibitory effects of a 5-HT3 antagonist on 
drug-induced stimulation of dopamine release. Eur J Pharmacol. 1989; 164:515–519. [PubMed: 
2767122] 
Ding ZM, Liu W, Engleman EA, Rodd ZA, McBride WJ. Differential effects of dopamine D2 and 
GABA-A receptor antagonists on dopamine neurons between the anterior and posterior ventral 
tegmental area of female Wistar rats. Pharmacol Biochem Behav. 2009a; 92:404–412. [PubMed: 
19480073] 
Ding Z-M, Rodd ZA, Engleman EA, McBride WJ. Sensitization of ventral tegmental area dopamine 
neurons to the stimulating effects of ethanol. Alcohol Clin Exp Res. 2009b (E-pub ahead of print). 
Fadda F, Garau B, Marchei F, Colombo G, Gessa GL. MDL 72222, a selective 5-HT3 receptor 
antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats. Alcohol Alcohol. 
1991; 26:107–110. [PubMed: 1878073] 
Ford MM, Yoneyama N, Strong MN, Fretwell A, Tanchuck T, Finn DA. Inhibition of 5α-reduced 
steroid biosynthesis impedes acquisition of ethanol drinking in male C57BL/6J mice. Alcohol Clin 
Exp Res. 2008; 32:1408–1416. [PubMed: 18565155] 
Gatto GJ, McBride WJ, Murphy JM, Lumeng L, Li TK. Ethanol self-infusion into the ventral 
tegmental area by alcohol-preferring rats. Alcohol. 1994; 11:557–564. [PubMed: 7865158] 
Herve D, Pickel VM, Joh TH, Beaudet A. Serotonin axon terminals in the ventral tegmental area of the 
rat: fine structure and synaptic input to dopaminergic neurons. Brain Res. 1987; 435:71–83. 
[PubMed: 2892580] 
Rodd et al. Page 14
Alcohol. Author manuscript; available in PMC 2015 July 27.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Hodge CW, Haraguchi M, Erickson H, Samson HH. Ventral tegmental microinjections of quinpirole 
decrease ethanol and sucrose-reinforced responding. Alcohol Clin Exp Res. 1993a; 17:370–375. 
[PubMed: 8098187] 
Hodge CW, Samson HH, Lewis RS, Erickson HL. Specific decreases in ethanol- but not water-
reinforced responding produced by the 5-HT3 antagonist ICS 205-930. Alcohol. 1993b; 10:191–
196. [PubMed: 8507386] 
Hodge CW, Haraguchi M, Chappelle AM, Samson HH. Effects of ventral tegmental microinjections of 
the GABA-A agonist muscimol on self-administration of ethanol and sucrose. Pharmacol Biochem 
Behav. 1996; 53:971–977. [PubMed: 8801605] 
Ikemoto S, Murphy JM, McBride WJ. Self-infusion of GABA-A receptor antagonists directly into the 
ventral tegmental area and adjacent regions. Behav Neurosci. 1997a; 110:331–345. [PubMed: 
8731060] 
Ikemoto S, McBride WJ, Murphy JM, Lumeng L, Li TK. 6-OHDA-lesions of the nucleus accumbens 
disrupt the acquisition but not the maintenance of ethanol consumption in the alcohol-preferring P 
line of rats. Alcohol Clin Exp Res. 1997b; 21:1042–1046. [PubMed: 9309315] 
Ikemoto S, Kohl RR, McBride WJ. GABA-A receptor blockade in the anterior ventral tegmental area 
increases extracellular levels of dopamine in the nucleus accumbens of rats. J Neurochem. 1997c; 
69:137–143. [PubMed: 9202304] 
Ikemoto S, Murphy JM, McBride WJ. Regional differences within the rat ventral tegmental area for 
muscimol self-infusions. Pharmacol Biochem Behav. 1998; 61:87–92. [PubMed: 9715810] 
Katner SN, McBride WJ, Lumeng L, Li TK, Murphy JM. Alcohol intake of P rats is regulated by 
muscarinic receptors in the pedunculopontine nucleus and VTA. Pharmacol Biochem Behav. 
1997; 58:497–504. [PubMed: 9300611] 
Klein RL, Sanna E, McQuilkin SJ, Whiting PJ, Harris RA. Effects of 5-HT3 receptor antagonists on 
binding and function of mouse and human GABA-A receptors. Eur J Pharmacol. 1994; 268:237–
246. [PubMed: 7957645] 
Knapp DJ, Pohorecky LA. Zacopride, a 5-HT3 receptor antagonist, reduces voluntary ethanol 
consumption in rats. Pharmacol Biochem Behav. 1992; 41:847–850. [PubMed: 1594653] 
Koob GF, Roberts AN, Schulteis G, Parsons LH, Heyser CJ, Hyytia P, Merlopich E, Weiss F. 
Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res. 1998; 22:3–9. 
[PubMed: 9514280] 
Liu W, Thielen RJ, McBride WJ. Effects of repeated daily treatments with a 5-HT3 receptor antagonist 
on dopamine neurotransmission and functional activity of 5-HT3 receptors within the nucleus 
accumbens of Wistar rats. Pharmacol Biochem Behav. 2006a; 84:370–377. [PubMed: 16828150] 
Liu W, Thielen RJ, Rodd ZA, McBride WJ. Activation of serotonin-3 receptors increases dopamine 
release within the ventral tegmental area of Wistar and alcohol-preferring (P) rats. Alcohol. 2006b; 
40:167–176. [PubMed: 17418696] 
Lovinger DM, White G. Ethanol potentiation of 5-hydroxytryptamine-3 receptor-mediated ion current 
in neuroblastoma cells and isolated adult mammalian neurons. Mol Pharmacol. 1991; 40:263–270. 
[PubMed: 1715016] 
McKinzie DL, Eha R, Cox R, Stewart RB, Dyr W, Murphy JM, McBride WJ, Lumeng L, Li TK. 
Serotonin-3 receptor antagonism of alcohol intake: Effects of drinking conditions. Alcohol. 1998; 
15:291–298. [PubMed: 9590513] 
McKinzie DL, McBride WJ, Murphy JM, Lumeng L, Li TK. Effects of MDL 72222, a serotonin-3 
antagonist, on operant responding for ethanol by alcohol-preferring P rats. Alcohol Clin Exp Res. 
2000; 24:1500–1504. [PubMed: 11045857] 
Minabe Y, Ashby CR, Schwartz JE, Wang RY. The 5-HT3 receptor antagonists LY277359 and 
granisetron potentiate the suppressant actions of apomorphine on the basal firing rate of ventral 
tegmental dopamine cells. Eur J Pharmacol. 1991; 209:143–150. [PubMed: 1665793] 
Nowak KL, McBride WJ, Lumeng L, Li TK, Murphy JM. Blocking GABA-A receptors in the anterior 
ventral tegmental area attenuates ethanol intake of the alcohol-preferring P rat. 
Psychopharmacology. 1998; 139:108–116. [PubMed: 9768548] 
Rodd et al. Page 15
Alcohol. Author manuscript; available in PMC 2015 July 27.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Nowak KL, McBride WJ, Lumeng L, Li TK, Murphy JM. Involvement of dopamine D2 autoreceptors 
in the ventral tegmental area on alcohol and saccharin intake of the alcohol-preferring P rat. 
Alcohol Clin Exp Res. 2000; 24:476–483. [PubMed: 10798583] 
Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. 4. Academic Press; New York: 1998. 
Prisco S, Pessia M, Ceci A, Borsini F, Esposito E. Chronic treatment with DAU6215, a new 5-HT3 
receptor antagonist, causes a selective decrease in the number of spontaneously active 
dopaminergic neurons in the rat ventral tegmental area. Eur J Pharmacol. 1992; 214:13–19. 
[PubMed: 1582449] 
Rasmussen K, Stockton ME, Czachura JF. The 5-HT3 receptor antagonist zatosetron decreases the 
number of spontaneously active A10 dopamine neurons. Eur J Pharmacol. 1991; 205:113–116. 
[PubMed: 1811993] 
Rodd ZA, Melendez RI, Bell RL, Kuc KA, Zhang Y, Murphy JM, McBride WJ. Intracranial self-
administration of ethanol within the ventral tegmental area of male Wistar rats: Evidence for 
regional heterogeneity and involvement of dopamine neurons. J Neurosci. 2004; 24:1050–1057. 
[PubMed: 14762123] 
Rodd ZA, Bell RL, Kuc KA, Zhang Y, Murphy JM, McBride WJ. Intracranial self-administration of 
cocaine within the posterior ventral tegmental area of Wistar rats: evidence for involvement of 
serotonin-3 receptors and dopamine neurons. J Pharmacol Exp Ther. 2005a; 313:134–145. 
[PubMed: 15650115] 
Rodd ZA, Bell RL, Zhang Y, Murphy JM, Goldstein A, Zaffaroni A, Li TK, McBride WJ. Regional 
heterogeneity for the intracranial self-administration of ethanol and acetaldehyde within the 
ventral tegmental area of alcohol-preferring (P) rats: involvement of dopamine and serotonin. 
Neuropsychopharmacology. 2005b; 30:330–338. [PubMed: 15383830] 
Rodd ZA, Bell RL, McQueen VK, Davids MR, Hsu CC, Murphy JM, Li TK, Lumeng L, McBride WJ. 
Chronic ethanol drinking by alcohol-preferring (P) rats increases the sensitivity of the posterior 
ventral tegmental area to the reinforcing effects of ethanol. Alcohol Clin Exp Res. 2005c; 29:358–
366. [PubMed: 15770111] 
Rodd ZA, Bell RL, McQueen VK, Davids MR, Hsu CC, Murphy JM, Li TK, Lumeng L, McBride WJ. 
Prolonged increase in the sensitivity of the posterior ventral tegmental area to the reinforcing 
effects of ethanol following repeated exposure to cycles of ethanol access and deprivation. J 
Pharmacol Exp Ther. 2005d; 315:648–657. [PubMed: 16076936] 
Rodd ZA, Gryszowka VE, Toalston JE, Oster SM, Ji D, Bell RL, McBride WJ. The reinforcing actions 
of a serotonin-3 receptor agonist within the ventral tegmental area: Evidence for subregional and 
genetic differences and involvement of dopamine neurons. J Pharmacol Exp Ther. 2007; 
321:1003–1012. [PubMed: 17325230] 
Rodd-Henricks ZA, McKinzie DL, Crile RS, Murphy JM, McBride WJ. Regional heterogeneity for the 
intracranial self-administration of ethanol within the ventral tegmental area of female Wistar rats. 
Psychopharmacology. 2000; 149:217–224. [PubMed: 10823401] 
Rodd-Henricks ZA, Bell RL, Kuc KA, Murphy JM, McBride WJ, Lumeng L, Li TK. Effects of 
ethanol exposure on subsequent acquisition and extinction of ethanol self-administration and 
expression of alcohol-seeking behavior in adult alcohol-preferring (P) rats: II. Adult exposure. 
Alcohol Clin Exp Res. 2002; 26:1642–1652. [PubMed: 12436052] 
Rodd-Henricks ZA, McKinzie DL, Melendez RI, Berry N, Murphy JM, McBride WJ. Effects of 
serotonin-3 receptor antagonists on the intracranial self-administration of ethanol within the 
ventral tegmental area of Wistar rats. Psychopharmacology. 2003; 165:252–259. [PubMed: 
12447605] 
Sung KW, Engel SR, Allan AM, Lovinger DM. 5-HT3 receptor function and potentiation by alcohols 
in frontal cortex neurons from transgenic mice over expressing the receptor. Neuropharmacology. 
2000; 39:2346–2351. [PubMed: 10974318] 
Svensson L, Fahlke C, Hard E, Engel JA. Involvement of the serotonergic system in ethanol intake in 
the rat. Alcohol. 1993; 10:219–224. [PubMed: 8507391] 
Toalston JE, Oster SM, Kuc K, Pommer TJ, Murphy JM, Lumeng L, Bell RL, McBride WJ, Rodd ZA. 
Effects of alcohol and saccharin deprivations on concurrent ethanol and saccharin operant self-
administration by alcohol-preferring (P) rats. Alcohol. 2008; 42:277–284. [PubMed: 18400451] 
Rodd et al. Page 16
Alcohol. Author manuscript; available in PMC 2015 July 27.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Tomkins DM, Le AD, Sellers EM. Effect of the 5-HT3 antagonist ondansetron on voluntary ethanol 
intake in rats and mice maintained on a limited access procedure. Psychopharmacology. 1995; 
117:479–485. [PubMed: 7604151] 
Van Bockstaele EJ, Cestari DM, Pickel VM. Synaptic structure and connectivity of serotonin terminals 
in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons. 
Brain Res. 1994; 647:307–322. [PubMed: 7522922] 
Wozniak KM, Pert A, Linnoila M. Antagonism of 5-HT3 receptors attenuates the effects of ethanol on 
extracellular dopamine. Eur J Pharmacol. 1990; 187:287–290. [PubMed: 2272364] 
Rodd et al. Page 17
Alcohol. Author manuscript; available in PMC 2015 July 27.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Fig. 1. 
Representative injection sites in the anterior and posterior VTA of P rats. Overlapping 
injection sites are not indicated. Closed circles represent injection sites within the posterior 
VTA (defined as –5.3 to –6.0 mm Bregma), and closed squares represent injection sites 
within the anterior VTA (defined as –4.8 to –5.2 mm Bregma). On the right hand side are 
photomicrographs which indicate an anterior (top) and posterior (bottom) VTA dual 
placement.
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Fig. 2. 
Number of EtOH responses (FR1) ± SEM following microinjections of ICS205-930 into the 
posterior VTA during acquisition of ethanol self-administration. Asterisks (*) indicate that 
rats bilaterally infused with 0.125, 0.25 or 1.25 μg/side of ICS responded significantly less 
than all other groups. Plus (+) symbol indicates that rats bilaterally infused with 0.125 or 
1.25 μg/side of ICS responded significantly less than all other groups. Pound (#) symbols 
indicate that rats that received ICS during the injection period responded more for ethanol 
than no injection and aCSF controls.
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Fig. 3. 
Number of water responses (FR1) ± SEM following microinjections of ICS into the 
posterior VTA during acquisition of ethanol self-administration. ICS did not alter water 
responding.
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Fig. 4. 
Number of ethanol responses (FR5) ± SEM following microinjections of ICS205-930 into 
the posterior VTA during maintenance of ethanol self-administration. Single asterisk 
indicates that rats bilaterally infused with 1.25 μg/side of ICS responded significantly more 
than the aCSF group. Plus symbols indicate that rats that received bilaterally microinjections 
of 1.0 and 1.25 μg/side of ICS responded more for ethanol than aCSF controls and 0.25, 0.5 
μg/side of ICS groups. Pound symbols indicate that rats that received 0.75, 1.0 and 1.25 μg/
side of ICS responded more for ethanol than all other groups. Double Asterisks indicate that 
rats that received 0.75 and 1.0 μg/side of ICS responded more for ethanol than all other 
groups.
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Fig. 5. 
Number of saccharin responses (FR5) ± SEM following microinjections of ICS205-930 into 
the posterior VTA during maintenance of Saccharin self-administration. Microinjections of 
ICS into the posterior VTA did not alter saccharin self-administration.
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Fig. 6. 
Number of ethanol responses (FR5) ± SEM following microinjections of ICS205-930 into 
the anterior VTA during maintenance of ethanol self-administration. Microinjections of ICS 
into the anterior VTA did not alter ethanol self-administration.
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